TRDA
Entrada Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$6.75
−2.17%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 11.21x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.13x
- Price / sales
- 56.09x
- Price / cash flow
- -1.95x
Enterprise value
- Enterprise value
- $88.4M
- EV / sales
- 18.86x
- EV / EBITDA
- -0.54x
- EV / EBIT
- -0.50x
- Market cap
- $262.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026